# Pylum Biosciences, Inc. — Form D

Pylum Biosciences, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-06. The offering totals $1.0M, of which $990K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-03-06
- Form: D
- Accession: 0001805522-20-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $1.0M
- Amount sold: $990K
- Remaining: $10K
- Investors: 29
- Date of first sale: 2020-02-21
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-362131

## Issuer

- Name: Pylum Biosciences, Inc.
- CIK: 0001805522
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 100 KIMBALL WAY, SOUTH SAN FRANCISCO, CA, 94080
- Phone: (650) 243-2951

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Miguel Barbosa | Director | South San Francisco, CA |
| Kevin Cameron | Director | Cambridge, MA |
| James Knighton | Director | South San Francisco, CA |
| David Martin | Director | Dublin 1, L2 |
| Jeffrey Miller | Director | San Mateo, CA |
| Stephen Creager | Executive Officer | South San Francisco, CA |
| James Knighton | Executive Officer | South San Francisco, CA |

## More

- [CIK 1805522 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1805522&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001805522-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.